BioLife Solutions (BLFS) Tops Q4 EPS by 4c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $38.61 --0%
EPS Growth %: +400.0%
Financial Fact:
Amortization of deferred financing costs: 0
Today's EPS Names:
LTBR, AES, SYRS, More
EPS Growth %: +400.0%
Financial Fact:
Amortization of deferred financing costs: 0
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $22.03 million.
GUIDANCE:
BioLife Solutions sees FY2025 revenue of $95.5-99 million, versus the consensus of $95.45 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- aTyr Pharma (LIFE) Reports Q3 EPS of $0.53; Offers Guidance
- Neurocrine Biosciences (NBIX) Tops Q3 EPS by 138c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
